Logo Image
|Slideshows|February 28, 2020

Psychiatric Times

  • Vol 37, Issue 2
  • Volume 37
  • Issue 2

In This Issue of Psychiatric Times: Vol 37, No 2

Author(s)Laurie Martin

Read the Psychiatric Times February 2020 issue cover-to-cover, with a bonus PDF.

Articles in this issue

over 6 years ago

Chaos Theory With a Human Face: Niall McLaren, MBBS, FRANZCP

over 6 years ago

Introduction: Trauma and Its Psychiatric Consequences

over 6 years ago

Violent Behavior and Involuntary Commitment: Ethical and Clinical Considerations

over 6 years ago

Pharmacological Management of Violence and Violent Behavior in Psychiatric Settings

over 6 years ago

Stroke in Young Adults: The Lasting Effects of Trauma

over 6 years ago

The Non-Binary Story and the Rescue of Self: Healing Stories of the Third Kind

over 6 years ago

The Show Must Go On

over 6 years ago

Psychiatric Malpractice Grand Rounds: Addiction Psychiatry

over 6 years ago

The Arms of Ivy Welcome Her

over 6 years ago

Bipolar Disorder: Practice-Changing Trials from 2019

Related Content

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

View more
(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more